Labiana Health SA
MAD:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Labiana Health SA
Cash from Financing Activities
Labiana Health SA
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Labiana Health SA
MAD:LAB
|
Cash from Financing Activities
€571.7k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Almirall SA
MAD:ALM
|
Cash from Financing Activities
-€87.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-2%
|
|
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Cash from Financing Activities
-€47.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
F
|
Faes Farma SA
MAD:FAE
|
Cash from Financing Activities
€273.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Laboratorio Reig Jofre SA
MAD:RJF
|
Cash from Financing Activities
€16.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Labiana Health SA
Glance View
Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.
See Also
What is Labiana Health SA's Cash from Financing Activities?
Cash from Financing Activities
571.7k
EUR
Based on the financial report for Dec 31, 2024, Labiana Health SA's Cash from Financing Activities amounts to 571.7k EUR.
What is Labiana Health SA's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-50%
Over the last year, the Cash from Financing Activities growth was -87%. The average annual Cash from Financing Activities growth rates for Labiana Health SA have been -68% over the past three years , -50% over the past five years .
